GAMT p.Asp93=
c.279C>T · rs144630886 · VCV137434
ClinGen expert panel — Cerebral Creatine Deficiency Syndromes VCEP
Benign for guanidinoacetate methyltransferase deficiency. Applied ACMG criteria (verbatim):
BP7 BP4 BA1
Curation rationale (ClinGen, verbatim)
The NM_000156.6:c.279C>T (p.Asp93=) is a synonymous variant in GAMT that is predicted to not impact splicing by SpliceAI and VarSeak, and the nucleotide is not highly conserved (BP4, BP7). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00484 (87/17976 alleles) in the East Asian population, which is higher than the ClinGen CCDS VCEP’s threshold for BA1 (>0.003), and therefore meets this criterion (BA1). This variant does not appear to have been previously reported in the published literature. It is noted in ClinVar (Variation ID 137434). In summary, this variant meets the criteria to be classified as benign for GAMT deficiency. GAMT-specific ACMG/AMP codes met, as specified by the ClinGen CCDS VCEP (Specifications Version 1.1.0): BA1, BP4, BP7. (Classification approved by the ClinGen CCDS VCEP on June 6, 2022).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -8.3 | GERP -3.1 |
| Overall | ||
| CADD | 0.881 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.257% | 389 |
| Middle Eastern | 0.0828% | 1,208 |
| Remaining individualsnot grpmax-eligible | 0.0502% | 1,992 |
| South Asian | 0.025% | 4,007 |
| European (non-Finnish) | 0.0202% | 4,943 |
| Admixed American | 0.0087% | 11,494 |
| Finnishnot grpmax-eligible | 0.0049% | 20,393 |
| African / African-American | 0.00268% | 37,347 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GAMT
- Protein
- p.Asp93=
- Coding
- c.279C>T
- MANE Select
- NM_000156
- dbSNP
- rs144630886
- Type
- single nucleotide variant
- Location
- chr19:1399841 (GRCh38)
- Gene constraint
- LOEUF 1.536 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 96.73 · 1 PDB
- Residue 93
- the rmt2 domain; an α-helix
Disease context
guanidinoacetate methyltransferase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: cerebral creatine deficiency syndrome
For Guanidinoacetate methyltransferase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
Similar variants
- GAMT p.Asp93Val Uncertain significance ★ ⚠ same residue
- GAMT p.Asp93Glu Uncertain significance ⚠ same residue
- GAMT c.327+43G>A Likely pathogenic ★★★ same condition
- GAMT c.328-1G>A Pathogenic ★★★ same condition
- GAMT c.328-2A>G Pathogenic ★★★ same condition
- GAMT c.391+15G>T Likely pathogenic ★★★ same condition
- GAMT c.391+1G>C Pathogenic ★★★ same condition
- GAMT c.391+5G>C Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gamt-p-asp93 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown